Experimental drug for heparin-triggered blood disorder tested, but study stopped early
Disease control
Terminated
This study tested a new drug called VLX-1005 for a rare condition where the blood thinner heparin causes low platelet counts and dangerous blood clots. About 24 adults with suspected heparin-induced thrombocytopenia were randomly assigned to receive either VLX-1005 or a placebo, …
Phase: PHASE2 • Sponsor: Veralox Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:09 UTC